Skip to main content

Military Health System

USU cohort study investigates COVID-19 impacts on DOD personnel

Image of Military health personnel wearing a mask and a face shield holding up a sign that has the number eighteen on it . Navy Hospital Corpsman 3rd Class Charles Cambern holds up a numbered sign as patients circle through to receive the COVID-19 vaccine at Walter Reed National Military Medical Center, in Bethesda, Maryland. WRNMMC is one of 10 DOD sites undertaking the EPICC study to better understand COVID-19 disease. (U.S. Navy photo by Ricardo Reyes)

Recommended Content:

Immunizations | COVID-19 Vaccine Efforts | Coronavirus & the MHS Response

The Uniformed Services University of the Health Sciences’ Infectious Disease Clinical Research Program is leading a multi-year study to identify risk factors for COVID-19 in the military population, understand the symptoms and disease course, and investigate clinical outcomes.

Epidemiology, Immunology, and Clinical Characteristics of Emerging Infectious Diseases with Pandemic Potential – or EPICC – study hopes to inform the Military Health System on ways to improve the patient care and treatment, infection, and disease prevention of those with COVID-19. USU is working in partnership with a network of military commands, treatment facilities, and laboratories across the country for EPICC.

Findings from the study “will support further understanding of the impact of SARS-COV-2 infection on active-duty readiness, acute and chronic clinical outcomes, the effectiveness of new treatments and vaccines, and address questions related to the emergence of new variants and their clinical impact,” said Dr. Brian Agan, deputy science director of IDCRP and principal investigator of the study.

The study is also evaluating how long the immune response to the COVID-19 vaccines lasts, breakthrough infections – which happen when a vaccinated individual becomes sick from the same illness the vaccination is designed to prevent – and how they behave over time, and estimating vaccine effectiveness, said Agan, who is also an employee of the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.

Department of Defense service members and MHS beneficiaries of any age with COVID-19-like illness who are admitted to the hospital or treated as outpatients at an EPICC site can join. Likewise, those 18 years or older who have been tested for COVID-19, whether they tested positive or negative, can participate in the online portion of the study, which includes self-collected blood specimens for selected participants.

The protocol was recently updated to also enroll COVID-19 vaccine recipients and will initiate recruitment upon approval, said Navy Capt. (Dr.) Timothy Burgess, program director of IDCRP, who oversees the study. Eligible beneficiaries who are interested in participating in EPICC can submit an online screening form to join.

“In addition, asymptomatic individuals with a high risk of exposure are also eligible for enrollment in EPICC, which includes health care workers and close contacts of cases,” said Burgess. “Particularly, health care workers who have received a COVID-19 vaccination will be an important population for studies to examine vaccine effectiveness and outcomes.”

Data from inpatient, outpatient, and online participants, including their clinical characteristics, comorbidities, the clinical course of their illness, treatment, immunology, and outcomes, is being collected for the study.

“Questionnaires are provided to enrollees to collect information on demographics, symptoms at initial presentation and chronic or persisting symptoms during follow-up, exposure history, and lifestyle factors,” said Burgess. “Clinical and research specimens collected from enrollees are examined using molecular, serological, and other immune assays in collaboration USU and non-USU partner laboratories.”

Initiated in March 2020, EPICC is expected to continue enrolling participants at least through March 2022, or for as long as needed to fill in the knowledge gaps related to this disease, explained Agan.

“Once enrolled, participants are actively followed for one year to fully capture specimens and data including chronic outcomes and sequelae and will be followed for up to four additional years through electronic medical record review,” Agan said.

EPICC is being conducted at 10 military medical treatment facilities throughout the United States:

  • Brooke Army Medical Center in Fort Sam Houston, Texas
  • Carl R. Darnall Army Medical Center in Fort Hood, Texas
  • Fort Belvoir Community Hospital in Fort Belvoir, Virginia
  • Joint Base Lewis-McChord, Washington
  • Naval Medical Center Portsmouth in Portsmouth, Virginia
  • Naval Medical Center San Diego in San Diego, California
  • Tripler Army Medical Center in Honolulu, Hawaii
  • William Beaumont Army Medical Center in El Paso, Texas
  • Womack Army Medical Center in Fort Bragg, North Carolina
  • Walter Reed National Military Medical Center in Bethesda, Maryland

Military health personnel wearing a face mask and shield speaking to a man who is wearing a face mask
Navy Hospital Corpsman 3rd Class Michael A. Torrent conducts a pre-screening questionnaire prior to administering the COVID-19 vaccine as part of Operation Warp Speed at Walter Reed National Military Medical Center. (U.S. Navy photo by Ricardo Reyes)

By the first week of February, more than 1,600 active-duty service members and MHS beneficiaries had enrolled in EPICC, the majority of whom are being treated as outpatients, said Agan. Approximately half of the subjects with confirmed SARS-CoV-2 diagnoses included in EPICC are active-duty service members.

Some interesting observations the researchers found thus far are that the characteristics of hospitalized COVID-19 patients compared to those treated as outpatients has shown a higher proportion of comorbidities, with hypertension, diabetes, and obesity being most prevalent, said Agan. In fact, their findings have begun to identify why obesity is a risk factor for more severe disease.

They were also able to garner valuable insight into the risk of reinfection from a military health care worker enrolled in the study who was reinfected with a symptomatic case of COVID-19. 

“A median time to recovery has been identified as 14 days, with nine lost duty days among active-duty service members,” said Agan. “These findings not only support operational planning, but also provide an important baseline to evaluate the effectiveness of vaccines as uptake widens across the DOD.”

They also found that the antibody levels that cause immunity remain in individuals for more than six months post-infection and that there were no “seroreversions” after six months post-infection. Seroreversion is the loss of serologic reactivity, or the presence of a particular antigen in the blood, whether spontaneous or in response to therapy. 

“With ongoing concerns about the magnitude and duration of immunity post-infection, our findings were both surprising and a relief,” said Burgess.

The researchers hope the information on the effectiveness and safety of the vaccines will alleviate concerns and encourage individuals to be vaccinated. And as the vaccine rollout expands to more recipients, the study will benefit from recruiting participants among the growing population of vaccinated recipients.

“This will enhance our ability to evaluate vaccine effectiveness in the population and if other reports showing high levels of protection are confirmed, our work may help boost confidence among those who are less certain,” said Burgess. “We are excited about the ability of the EPICC study to answer key questions for patients, health care providers, and leadership to guide decisions as we steer through the coming months of this unprecedented and historic pandemic.

You also may be interested in...

Spread Facts, Not the Flu

Infographic
5/25/2022
Spread Facts, Not the Flu

How to prevent spread of the flu

Recommended Content:

Seasonal Influenza Vaccine Toolkit | Prevent the Flu | Immunizations

National Infant Immunization Week

Infographic
3/15/2022
National Infant Immunization Week

It’s more important than ever to help protect children from vaccine-preventable diseases. This #NationalInfantImmunizationWeek make sure your child and children around them are safe by ensuring your infant is properly vaccinated.

Recommended Content:

April | Immunizations | Children's Health

COVID-19 Booster Shots

Infographic
8/27/2021
COVID-19 Booster Shots

If you have an immune system that is moderately to severely compromised, the CDC recommends you may receive an additional dose of mRNA COVID-19 vaccine (Pfizer or Moderna). This would be at least 4 weeks after your second dose.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Coronavirus & the MHS Response | COVID-19 Vaccine Efforts

Mask Guidance for Department of Defense Facilities

Infographic
7/30/2021
Mask Guidance for Department of Defense Facilities

In accordance with CDC guidance, the Department of Defense (DOD) requires all Service members, Federal employees, onsite contractor employees, and visitors, regardless of vaccination status, to wear a mask in all indoor DOD facilities. If you are not vaccinated, continue to physically distance consistent with applicable CDC and DOD Force Health Protection Guidance.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Coronavirus & the MHS Response | COVID-19 Vaccine Efforts

COVID-19: Get Your Second Shot

Infographic
6/22/2021
COVID-19: Get Your Second Shot

You're not fully vaccinated - or protected - until two weeks after getting your second shot of the Pfizer or Moderna vaccine.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Get to Know the COVID-19 Vaccines | COVID-19 Vaccine Efforts

How COVID-19 Vaccines Work

Infographic
6/9/2021
How COVID-19 Vaccines Work

This graphic showing how the mRNA and viral vector vaccines work to educate beneficiaries about the COVID-19 vaccines. Graphics are informational and provide facts on how they work in our bodies.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Get to Know the COVID-19 Vaccines | COVID-19 Vaccine Efforts | COVID-19 Vaccine Efforts

Get to Know the COVID-19 Vaccines - Main Infographic

Infographic
6/9/2021
Get to Know the COVID-19 Vaccines - Main Infographic

This infographic pulls all three COVID-19 topics together in one graphic: Getting to Know the COVID-19 Vaccines, How they Work and Safety Monitoring

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Get to Know the COVID-19 Vaccines | COVID-19 Vaccine Efforts | COVID-19 Vaccine Efforts

COVID-19 Vaccines Safety Monitoring

Infographic
6/9/2021
COVID-19 Vaccines Safety Monitoring

Graphic that assures beneficiaries that the COVID-19 vaccines are monitored for safety. Has information on how they are being reviewed. Graphics include doctors in a laboratory and a doctor with a shield fending off the virus.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Get to Know the COVID-19 Vaccines | COVID-19 Vaccine Efforts | COVID-19 Vaccine Efforts

Get to Know the COVID-19 Vaccines

Infographic
6/9/2021
Get to Know the COVID-19 Vaccines

This graphic that assures beneficiaries that the vaccines will not give you the virus, does not affect our DNA, and is safe. Graphics include a person receiving the vaccine and a comparison graphic of COVID-19 trials versus other trials.

Recommended Content:

Get to Know the COVID-19 Vaccines | Coronavirus and the COVID-19 Vaccine | COVID-19 Vaccine Efforts | COVID-19 Vaccine Efforts

COVID-19 Vaccination Card Second Shot

Infographic
5/27/2021
COVID-19 Vaccination Card Second Shot

Keep track of your vaccination card. Tips include keeping your card on you and taking a picture of it as a backup copy.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Coronavirus & the MHS Response

Is It Allergies or COVID-19?

Infographic
5/11/2021
Is It Allergies or COVID-19?

This Infographic provides a chart that outlines how to tell the difference between COVID-19 and allergy symptoms

Recommended Content:

Symptoms of COVID-19 | Coronavirus & the MHS Response | Coronavirus and the COVID-19 Vaccine

VAX Fact Protection Last

Infographic
4/19/2021
VAX Fact Protection Last

An infographic answering the question of how long the COVID-19 vaccine protection lasts.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Coronavirus and the COVID-19 Vaccine | Coronavirus & the MHS Response | COVID-19 Vaccine Efforts

VAX Fact Currently Pregnant

Infographic
4/19/2021
VAX Fact Currently Pregnant

An infographic answering the question of whether to get the COVID-19 vaccine if you're currently pregnant.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Coronavirus and the COVID-19 Vaccine | Coronavirus & the MHS Response | COVID-19 Vaccine Efforts

VAX Fact Other Medical Conditions

Infographic
4/19/2021
VAX Fact Other Medical Conditions

An infographic answering the question of whether you can get the COVID-19 vaccine if you have underlying medical conditions.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Coronavirus and the COVID-19 Vaccine | Coronavirus & the MHS Response | COVID-19 Vaccine Efforts

VAX Fact Affect Fertility

Infographic
4/19/2021
VAX Fact Affect Fertility

An infographic answering the question of whether the COVID-19 vaccine affects a person's fertility.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Coronavirus and the COVID-19 Vaccine | Coronavirus & the MHS Response | COVID-19 Vaccine Efforts
<< < 1 2 > >> 
Showing results 1 - 15 Page 1 of 2
Refine your search
Last Updated: September 27, 2022
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on YouTube Sign up on GovDelivery